Suppr超能文献

HS-142-1是一种新型利钠肽拮抗剂,对T84细胞中膜结合鸟苷酸环化酶(GC-C)的第三个成员没有影响。

HS-142-1, a novel antagonist for natriuretic peptides, has no effect on the third member of membrane bound guanylate cyclases (GC-C) in T84 cells.

作者信息

Ohyama Y, Miyamoto K, Morishita Y, Matsuda Y, Kojima M, Minamino N, Kangawa K, Matsuo H

机构信息

National Cardiovascular Center Research Institute, Osaka, Japan.

出版信息

Life Sci. 1993;52(17):PL153-7. doi: 10.1016/0024-3205(93)90071-a.

Abstract

HS-142-1, a novel non-peptide antagonist for natriuretic peptides, exerts antagonistic actions almost equally on two similar guanylate cyclase-linked natriuretic peptide receptors (GC-A and GC-B), but has little or no effect on the binding of natriuretic peptides to a membrane protein, the so-called "clearance receptor", which binds all natriuretic peptides. The third mammalian form of membrane bound guanylate cyclases (GC-C) was identified not as a natriuretic peptide receptor, but as a receptor for heat-stable enterotoxins (STa). In this study, we examined effects of HS-142-1 on GC-C (STaR) in T84 cells and showed that HS-142-1 exerts neither agonistic nor antagonistic activity for GC-C, indicating that HS-142-1 is not a common antagonist for a family of membrane bound guanylate cyclase receptors, but a specific antagonist for the guanylate cyclase-linked natriuretic peptide receptors.

摘要

HS-142-1是一种新型的利钠肽非肽拮抗剂,对两种相似的鸟苷酸环化酶连接型利钠肽受体(GC-A和GC-B)几乎具有同等的拮抗作用,但对利钠肽与一种膜蛋白(即所谓的“清除受体”,它能结合所有利钠肽)的结合几乎没有影响或完全没有影响。第三种哺乳动物形式的膜结合鸟苷酸环化酶(GC-C)并非被鉴定为利钠肽受体,而是热稳定肠毒素(STa)的受体。在本研究中,我们检测了HS-142-1对T84细胞中GC-C(STaR)的影响,结果表明HS-142-1对GC-C既无激动活性也无拮抗活性,这表明HS-142-1不是膜结合鸟苷酸环化酶受体家族的通用拮抗剂,而是鸟苷酸环化酶连接型利钠肽受体的特异性拮抗剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验